Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4917 total record number 289 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 305 out of 492
4917 citations found

CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice

Eldredge, LC;Treuting, PM;Manicone, AM;Ziegler, SF;Parks, WC;McGuire, JK;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo

Moro-Sibilot, L;This, S;Blanc, P;Sanlaville, A;Sisirak, V;Bardel, E;Boschetti, G;Bendriss-Vermare, N;Defrance, T;Dubois, B;Kaiserlian, D;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • In vivo treatments:

    To deplete pDCs, BDCA2-DTR mice were injected i.p. with 20 ng/g of DT (List Biological Laboratories, Campbell, CA, USA) on day 0 (or day 1 for oral immunization), then every other day with 10 ng/g. DT-treated WT littermates were used as controls. …CD4+ T-cell depletion was controlled in blood at day 0 before starting DT treatment and at sacrifice.

Regeneration in the Pituitary After Cell-Ablation Injury: Time-Related Aspects and Molecular Analysis

Willems, C;Fu, Q;Roose, H;Mertens, F;Cox, B;Chen, J;Vankelecom, H;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • DT treatment and blood sampling of mice:

    GHCre/iDTR mice and Cre-negative control littermates (referred to as /iDTR) of the indicated ages were injected ip with DT (4-ng/g body weight, twice a day at 9 am and 5 pm; List Biological Laboratories) for either 3 (3-d DT treatment [3DT]) or 10 (10DT) consecutive days. Three to 6 mice were used per condition in the independent experiments. …

    Blood samples (100 L) were taken retroorbitally at 9 am, first on the day before the start of DT treatment and then at 11 days (d11), 1.5, 12, and 15 months after DT initiation. …

Product: Cholera Toxin B Subunit (CTB) from Vibrio cholerae FITC, Conjugate

Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel -galactosidase:RTB lectin fusion

Condori, J;Acosta, W;Ayala, J;Katta, V;Flory, A;Martin, R;Radin, J;Cramer, CL;Radin, DN;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • …To detect GM1 ganglioside, cells were permeabilized, blocked with BSA-glycine, and then incubated with Cholera Toxin B protein (List Biologicals) that had been conjugated to Dylight 594 (CTXB- Dylight 594 ). Cells were subsequently counterstained with 600 nM DAPI and images acquired using the BD Pathway 855 High Content Bioimager (BD Biosciences) as described [24] . …

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Age-related changes in neurochemical components and retinal projections of rat intergeniculate leaflet

Fiuza, FP;Silva, KD;Pessoa, RA;Pontes, AL;Cavalcanti, RL;Pires, RS;Soares, JG;Nascimento Jnior, ES;Costa, MS;Engelberth, RC;Cavalcante, JS;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Intraocular tracer injection:

    Rats were anesthetized with a ketamine hydrochloride (80 mg/kg) and xylazin (20 mg/kg) intramuscular injection. Then, 18 µL of cholera toxin subunit b neural tracer (1 mg/mL; List Biological Laboratories, Campbell, CA) in a solution containing 10 % dimethylsulfoxide was injected into the vitreous chamber of one eye with a glass micropipette attached to a 10µL Hamilton syringe. After a 5-day post-surgery period, animals were submitted to the following procedures.

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Axon terminals from the nucleus isthmi pars parvocellularis control the ascending retinotectofugal output through direct synaptic contact with tectal ganglion cell dendrites

Gonzlez-Cabrera, C;Garrido-Charad, F;Mpodozis, J;Bolam, JP;Marn, GJ;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Somatostatin in the rat rostral ventrolateral medulla: Origins and mechanism of action

Bou Farah, L;Bowman, BR;Bokiniec, P;Karim, S;Le, S;Goodchild, AK;McMullan, S;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling

Binnington, B;Nguyen, L;Kamani, M;Hossain, D;Marks, DL;Budani, M;Lingwood, CA;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

  • Antibodies and Ligands:

    Cholera toxin B-subunit was from List Labs. …

    Results – Statins alter intracellular cholesterol and GCS distribution:

    In addition, 3-PEHPC mimicked rosuvastatin to disperse the elevated TGN cholesterol pool and prevent the Golgi/ER targeting of internalized Verotoxin or Cholera toxin B-subunits (Figure 7A). In control cells, VT-B and CT-B were rapidly internalized to the Golgi. Though some double-stained cells were evident, most cells bound either VT-B or CT-B, consistent with previously reported cell-cycle-dependent receptor Gb3 and GM1 expression (Majoul et al. 2002). In double-labeled ACHN cells, VT-B and CT-B are co-localized. In statin or 3-PEHPC-treated cells however, the distinct TGN cholesterol pool is diminished and VT-B/CT-B are detected more diffusely throughout the cell (Figure 7A). These changes were not observed in cells treated with FTI-277 or GGTI-2133. Multiple Rab GTPases have been implicated in this GSL-mediated transport route…

    Product #104 – Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to -Lactoglobulin-Derived Peptides

Kostadinova, AI;Meulenbroek, LA;van Esch, BC;Hofman, GA;Garssen, J;Willemsen, LE;Knippels, LM;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • OT Induction in a Mouse Model of Orally Induced CMA:

    Upon arrival, mice were fed the control or the FF/Bb diet ad libitum for a period of 9 days. During the OT phase, they received daily oral gavages with 0.5 mL PBS, PepMix (total 0.16 mg peptides/0.5 mL PBS; 0.04 mg of each BLG-derived peptide) or whole whey protein as a positive control for maximum OT induction (50 mg/0.5 mL PBS; DMV International, Veghel, The Netherlands) for a period of 6 days. In the first study (Figure 1), following the OT phase, all mice were fed the control diet and orally sensitized for five consecutive weeks with 10 µg cholera toxin (List Biological Laboratories, Inc., CA, USA) as an adjuvant with or without 0.5 mL homogenized whey (40 mg whey/mL PBS). …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae